T1	Participants 28 54	type II diabetes mellitus.
T2	Participants 76 272	To identify patients with type II diabetes mellitus for whom insulin therapy is most beneficial, we conducted a randomized controlled trial in the general medicine clinic of a university hospital.
T3	Participants 273 318	Asymptomatic, obese, insulin-treated patients
T4	Participants 563 593	25 insulin-withdrawal patients
T5	Participants 660 680	24 control subjects.
